Drupal.behaviors.print = function(context) {window.print();window.close();}>
Vermillion Reports OVA1 Tests Performed in 2010 Exceeds Guidance
January 05, 2011
Vermillion Reports OVA1 Tests Performed in 2010 Exceeds Guidance
The 6,155 tests done for the year exceeds the 5,000 to 5,500 that the company had expected.
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Vermillion's Q4 Revenues Increase 152 Percent on OVA1 Sales
March 27, 2012 / GenomeWeb Daily News
Vermillion's OVA1 Test Assigned Category 1 CPT Code; Stock Jumps
March 6, 2012 / GenomeWeb Daily News
Vermillion Shares Soar on Positive OVA1, Imaging Data
September 14, 2011 / GenomeWeb Daily News
Pronto Diagnostics to Distribute Vermillion's OVA Test in Israel, Palestinian Territories
August 3, 2011 / GenomeWeb Daily News
Vermillion Posts 8 Percent Increase in OVA1 Sales, Announces Shift in Commercialization Strategy
May 17, 2013 / ProteoMonitor